Oct. 26 at 12:16 AM
$VIR A-numbe of institutional investors have recently modified their holdings of the company. ARCH Venture Management LLC bought a new stake in Vir Biotechnology during the second quarter worth about
$65,100,000. Orbimed Advisors LLC raised its holdings in Vir Biotechnology by 5.9% during the second quarter. Orbimed Advisors LLC now owns 2,380,715 shares of the company's stock worth
$11,999,000 after acquiring an additional 132,466 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Vir Biotechnology by 9.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,374,874 shares of the company's stock worth
$8.X,909,000 after acquiring an additional 122,219 shares in the last quarter. Aberdeen Group plc raised its holdings in Vir Biotechnology by 45.3% during the second quarter. Aberdeen Group plc now owns 1,006,891 shares of the company's stock worth
$5,075,000 after acquiring an additional 313,699 shares in the last quart